As of May 2022 Samsung Biologics has a market cap of $45.14 Billion. This makes Samsung Biologics the world's 361th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $45.14 B | -10.09% |
2021 | $50.21 B | -0.18% |
2020 | $50.30 B | 103.04% |
2019 | $24.77 B | 8.15% |
2018 | $22.90 B | -0.19% |
2017 | $22.95 B | 176.89% |
2016 | $8.28 B |
On May 21st, 2022 the market cap of Samsung Biologics was reported to be: